SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Oruka Therapeutics says ORKA-001 on track for Phase 3 in 1H 2027

Valid market news retained in the public archive without immediate LiveCast distribution.

ORKA

Related stories